無菌注射剤受託製造市場、規模、シェア、動向、産業分析レポート：分子タイプ別、治療用途別、投与経路別、最終用途別、地域別 - 市場予測 2025年～2034年

Polaris Market Research社の最新調査によると、世界の無菌注射剤受託製造市場規模は2034年までに503億8,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

無菌注射剤受託製造市場は、生物製剤や複雑な医薬品製剤の需要増に牽引され、近年大きな成長を遂げています。ヘルスケア産業の発展に伴い、高度なドラッグデリバリーシステムと高品質の注射剤に対するニーズが最重要となっています。注射によって投与される広範な医薬品を含む無菌注射剤は、腫瘍学、糖尿病、ワクチンなど様々な治療分野で不可欠です。無菌注射剤は、迅速な治療効果が得られることと、低侵襲な治療オプションへの嗜好の高まりにより、支持を集めています。同市場は、製剤開発、充填・仕上げ作業、包装ソリューションなどの専門サービスを提供する多様な受託製造業者によって特徴付けられています。

この市場の成長に寄与する主な要因の一つは、慢性疾患の有病率の上昇と高齢化人口の増加であり、革新的な治療ソリューションが求められています。がん、自己免疫疾患、感染症などの疾患は注射療法を必要とすることが多いため、無菌注射剤のニーズが高まっています。さらに、個別化医療や生物製剤に対する需要の急増により、製薬会社はこれらの複雑な製剤の製造を専門とする製造受託機関（CMO）を求めるようになっています。

無菌注射剤受託製造市場レポートハイライト

分子タイプ別では、低分子セグメントの無菌注射剤受託製造市場は、新たな治療法に焦点を当てた研究開発が進行していることから、予測期間中に大幅な成長が見込まれます。

高分子セグメントは、生物製剤とバイオシミラーの普及が進んでいることから、2024年の市場を独占しています。

治療用途別では、世界のがん罹患率の上昇と革新的治療に対する需要の高まりにより、2024年にはがん分野が市場の主要シェアを占めました。

世界市場では、強固な医薬品インフラ、高いヘルスケア支出、技術革新と研究開発への強い注力により、北米が最大の収益シェアを占めています。

アジア太平洋市場は、医療インフラへの投資の増加と人口増加により、予測期間中に大きなCAGRを記録すると予測されます。

世界の主な市場参入企業は、Baxter; Catalent, Inc.; Vetter Pharma-Fertigung GmbH & Co. KG; NextPharma Technologies; Cipla; FAMAR Health Care Services; Unither Pharmaceuticals; Recipharm AB; Fresenius Kabi AG; Simtra BioPharma Solutions; and Aenova Group.などです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の無菌注射剤受託製造市場の洞察

• 市場スナップショット
• 無菌注射剤受託製造市場力学
  • 促進要因と機会
    • 慢性疾患の罹患率の上昇により、無菌注射剤受託製造市場が成長しています。
    • 技術の進歩により、無菌注射剤受託製造市場が推進されています。
  • 抑制要因と課題
    • 厳しい規制要件が世界市場の妨げとなっています。
• PESTEL分析
• 無菌注射剤受託製造市場の動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の無菌注射剤受託製造市場：分子タイプ別

• 主な調査結果
• イントロダクション
• 小分子
• 巨大分子

第6章 世界の無菌注射剤受託製造市場：治療用途別

• 主な調査結果
• イントロダクション
• がん
• 糖尿病
• 心血管疾患
• 中枢神経系
• 感染症
• 筋骨格系障害
• 抗ウィルス薬
• その他

第7章 世界の無菌注射剤受託製造市場：投与経路別

• 主な調査結果
• イントロダクション
• 皮下（SC）
• 静脈内（IV）
• 筋肉内（IM）
• その他

第8章 世界の無菌注射剤受託製造市場：最終用途別

• 主な調査結果
• イントロダクション
• 製薬会社
• バイオ医薬品企業
• その他

第9章 世界の無菌注射剤受託製造市場：地域

• 主な調査結果
• イントロダクション
  • 無菌注射剤受託製造市場評価：地域、2020～2034年
• 北米
  • 北米：分子タイプ別、2020～2034年
  • 北米：治療用途別、2020～2034年
  • 北米：投与経路別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：分子タイプ別、2020～2034年
  • 欧州：治療用途別、2020～2034年
  • 欧州：投与経路別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：分子タイプ別、2020～2034年
  • アジア太平洋地域：治療用途別、2020年～2034年
  • アジア太平洋地域：投与経路別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：分子タイプ別、2020～2034年
  • 中東・アフリカ：治療用途別、2020～2034年
  • 中東・アフリカ：投与経路別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：分子タイプ別、2020～2034年
  • ラテンアメリカ：治療用途別、2020～2034年
  • ラテンアメリカ：投与経路別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Baxter
• Catalent, Inc.
• Vetter Pharma-Fertigung GmbH & Co. KG
• NextPharma Technologies
• Cipla
• FAMAR Health Care Services
• Unither Pharmaceuticals
• Recipharm AB
• Fresenius Kabi AG
• Simtra BioPharma Solutions
• Aenova Group

List of Tables:

• Table 1 Global Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 2 Global Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 3 Global Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 4 Global Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 5 North America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 6 North America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 7 North America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 8 North America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 9 U.S.: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 10 U.S.: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 11 U.S.: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 12 U.S.: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 13 Canada: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 14 Canada: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 15 Canada: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 16 Canada: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 17 Europe: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 18 Europe: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 19 Europe: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 20 Europe: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 21 UK: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 22 UK: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 23 UK: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 24 UK: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 25 France: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 26 France: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 27 France: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 28 France: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 29 Germany: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 30 Germany: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 31 Germany: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 32 Germany: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 33 Italy: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 34 Italy: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 35 Italy: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 36 Italy: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 37 Spain: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 38 Spain: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 39 Spain: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 40 Spain: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 41 Netherlands: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 42 Netherlands: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 43 Netherlands: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 44 Netherlands: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 45 Russia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 46 Russia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 47 Russia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 48 Russia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 57 China: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 58 China: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 59 China: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 60 China: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 61 India: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 62 India: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 63 India: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 64 India: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 65 Malaysia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 66 Malaysia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 67 Malaysia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 68 Malaysia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 69 Japan: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 70 Japan: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 71 Japan: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 72 Japan: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 73 Indonesia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 74 Indonesia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 75 Indonesia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 76 Indonesia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 77 South Korea: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 78 South Korea: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 79 South Korea: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 80 South Korea: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 81 Australia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 82 Australia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 83 Australia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 84 Australia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 97 UAE: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 98 UAE: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 99 UAE: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 100 UAE: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 101 Israel: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 102 Israel: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 103 Israel: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 104 Israel: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 105 South Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 106 South Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 107 South Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 108 South Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 113 Latin America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 114 Latin America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 115 Latin America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 116 Latin America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 117 Mexico: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 118 Mexico: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 119 Mexico: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 120 Mexico: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 121 Brazil: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 122 Brazil: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 123 Brazil: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 124 Brazil: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 125 Argentina: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 126 Argentina: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 127 Argentina: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 128 Argentina: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• List of Figures:
• Figure 1. Global Sterile Injectable Contract Manufacturing Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Molecule Type
• Figure 7. Global Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Therapeutic Application
• Figure 9. Global Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2024 & 2034 (USD Billion)
• Figure 10. Market by Route of Administration
• Figure 11. Global Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2024 & 2034 (USD Billion)
• Figure 12. Market by End-use
• Figure 13. Global Sterile Injectable Contract Manufacturing Market, by End-use, 2024 & 2034 (USD Billion)

The global sterile injectable contract manufacturing market size is expected to reach USD 50.38 billion by 2034, according to a new study by Polaris Market Research. The report "Sterile Injectable Contract Manufacturing Market Size, Share, Trends, Industry Analysis Report: By Molecule Type (Small Molecules and Large Molecules), Therapeutic Application, Route of Administration, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The sterile injectable contract manufacturing market has seen significant growth in recent years, driven by the rising demand for biologics and complex pharmaceutical formulations. The need for advanced drug delivery systems and high-quality injectable products has become paramount as the healthcare industry evolves. Sterile injectables, which include a wide range of pharmaceuticals administered via injection, are essential in various therapeutic areas, including oncology, diabetes, and vaccines. Sterile injectables have gained traction due to their ability to provide rapid therapeutic effects and the increasing preference for minimally invasive treatment options. The market is characterized by a diverse landscape of contract manufacturers that offer specialized services, including formulation development, fill-finish operations, and packaging solutions.

One of the key factors contributing to the growth of this market is the rising prevalence of chronic diseases and the increasing aging population, which demands innovative treatment solutions. Conditions such as cancer, autoimmune disorders, and infectious diseases often require injectable therapies, thus amplifying the need for sterile injectables. Additionally, the surge in demand for personalized medicine and biologics has prompted pharmaceutical companies to seek contract manufacturing organizations (CMOs) that specialize in the production of these complex formulations.

Sterile Injectable Contract Manufacturing Market Report Highlights

By molecule type, the sterile injectable contract manufacturing market for the small molecules segment is expected to experience substantial growth during the forecast period due to the ongoing research and development activities focused on new therapies.

The large molecules segment dominated the market in 2024 due to the increasing prevalence of biologics and biosimilars

Based on therapeutic application, the cancer segment accounted for a major share of the market in 2024 due to the rising incidence of cancer worldwide and the increasing demand for innovative treatments.

In the global market, North America held the largest revenue share due to robust pharmaceutical infrastructure, high healthcare spending, and a strong focus on innovation and R&D.

The market in Asia Pacific is estimated to register a significant CAGR during the forecast period owing to the increasing investments in healthcare infrastructure and a rising population.

A few global key market players are Baxter; Catalent, Inc.; Vetter Pharma-Fertigung GmbH & Co. KG; NextPharma Technologies; Cipla; FAMAR Health Care Services; Unither Pharmaceuticals; Recipharm AB; Fresenius Kabi AG; Simtra BioPharma Solutions; and Aenova Group.

Polaris Market Research has segmented the sterile injectable contract manufacturing market report on the basis of molecule type, therapeutic application, route of administration, end-use, and region:

By Molecule Type Outlook (Revenue, USD Billion, 2020-2034)

• Small Molecules
• Large Molecules

By Therapeutic Application Outlook (Revenue, USD Billion, 2020-2034)

• Cancer
• Diabetes
• Cardiovascular Diseases
• Central Nervous Systems Diseases
• Infectious Disorders
• Musculoskeletal
• Anti-Viral
• Others

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

• Subcutaneous (SC)
• Intravenous (IV)
• Intramuscular (IM)
• Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Molecule Types
  • 3.2.1. Primary Molecule Types
  • 3.2.2. Secondary Molecule Types

4. Global Sterile Injectable Contract Manufacturing Market Insights

• 4.1. Sterile Injectable Contract Manufacturing Market - Market Snapshot
• 4.2. Sterile Injectable Contract Manufacturing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising prevalence of chronic illnesses is driving the sterile injectable contract manufacturing market.
    • 4.2.1.2. Increasing advancement in technology is propelling the sterile injectable contract manufacturing market.
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. The stringent regulatory requirements are hampering the global market.
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Sterile Injectable Contract Manufacturing Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Sterile Injectable Contract Manufacturing Market, by Molecule Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
• 5.3. Small Molecules
  • 5.3.1. Global Sterile Injectable Contract Manufacturing Market, by Small Molecules, by Region, 2020-2034 (USD Billion)
• 5.4. Large Molecules
  • 5.4.1. Global Sterile Injectable Contract Manufacturing Market, by Large Molecules, by Region, 2020-2034 (USD Billion)

6. Global Sterile Injectable Contract Manufacturing Market, by Therapeutic Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
• 6.3. Cancer
  • 6.3.1. Global Sterile Injectable Contract Manufacturing Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 6.4. Diabetes
  • 6.4.1. Global Sterile Injectable Contract Manufacturing Market, by Diabetes, by Region, 2020-2034 (USD Billion)
• 6.5. Cardiovascular Diseases
  • 6.5.1. Global Sterile Injectable Contract Manufacturing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
• 6.6. Central Nervous System
  • 6.6.1. Global Sterile Injectable Contract Manufacturing Market, by Central Nervous System, by Region, 2020-2034 (USD Billion)
• 6.7. Infectious Diseases
  • 6.7.1. Global Sterile Injectable Contract Manufacturing Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
• 6.8. Musculoskeletal
  • 6.8.1. Global Sterile Injectable Contract Manufacturing Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
• 6.9. Anti-Viral
  • 6.9.1. Global Sterile Injectable Contract Manufacturing Market, by Anti-Viral, by Region, 2020-2034 (USD Billion)
• 6.10. Others
  • 6.10.1. Global Sterile Injectable Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Sterile Injectable Contract Manufacturing Market, by Route of Administration

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
• 7.3. Subcutaneous (SC)
  • 7.3.1. Global Sterile Injectable Contract Manufacturing Market, by Subcutaneous (SC), by Region, 2020-2034 (USD Billion)
• 7.4. Intravenous (IV)
  • 7.4.1. Global Sterile Injectable Contract Manufacturing Market, by Intravenous (IV), by Region, 2020-2034 (USD Billion)
• 7.5. Intramuscular (IM)
  • 7.5.1. Global Sterile Injectable Contract Manufacturing Market, by Intramuscular (IM), by Region, 2020-2034 (USD Billion)
• 7.6. Other
  • 7.6.1. Global Sterile Injectable Contract Manufacturing Market, by Other, by Region, 2020-2034 (USD Billion)

8. Global Sterile Injectable Contract Manufacturing Market, by End-use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• 8.3. Pharmaceutical Companies
  • 8.3.1. Global Sterile Injectable Contract Manufacturing Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
• 8.4. Biopharmaceutical Companies
  • 8.4.1. Global Sterile Injectable Contract Manufacturing Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
• 8.5. Others
  • 8.5.1. Global Sterile Injectable Contract Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Sterile Injectable Contract Manufacturing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Sterile Injectable Contract Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Sterile Injectable Contract Manufacturing Market - North America
  • 9.3.1. North America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  • 9.3.3. North America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.3.4. North America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.3.5. Sterile Injectable Contract Manufacturing Market - US
    • 9.3.5.1. US: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.3.6. Sterile Injectable Contract Manufacturing Market - Canada
    • 9.3.6.1. Canada: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• 9.4. Sterile Injectable Contract Manufacturing Market - Europe
  • 9.4.1. Europe: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.5. Sterile Injectable Contract Manufacturing Market - UK
    • 9.4.5.1. UK: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.6. Sterile Injectable Contract Manufacturing Market - France
    • 9.4.6.1. France: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.7. Sterile Injectable Contract Manufacturing Market - Germany
    • 9.4.7.1. Germany: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.8. Sterile Injectable Contract Manufacturing Market - Italy
    • 9.4.8.1. Italy: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.9. Sterile Injectable Contract Manufacturing Market - Spain
    • 9.4.9.1. Spain: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.10. Sterile Injectable Contract Manufacturing Market - Netherlands
    • 9.4.10.1. Netherlands: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.11. Sterile Injectable Contract Manufacturing Market - Russia
    • 9.4.11.1. Russia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.4.12. Sterile Injectable Contract Manufacturing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• 9.5. Sterile Injectable Contract Manufacturing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.5. Sterile Injectable Contract Manufacturing Market - China
    • 9.5.5.1. China: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.6. Sterile Injectable Contract Manufacturing Market - India
    • 9.5.6.1. India: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.7. Sterile Injectable Contract Manufacturing Market - Malaysia
    • 9.5.7.1. Malaysia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.8. Sterile Injectable Contract Manufacturing Market - Japan
    • 9.5.8.1. Japan: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.9. Sterile Injectable Contract Manufacturing Market - Indonesia
    • 9.5.9.1. Indonesia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.10. Sterile Injectable Contract Manufacturing Market - South Korea
    • 9.5.10.1. South Korea: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.11. Sterile Injectable Contract Manufacturing Market - Australia
    • 9.5.11.1. Australia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.5.12. Sterile Injectable Contract Manufacturing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• 9.6. Sterile Injectable Contract Manufacturing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.6.5. Sterile Injectable Contract Manufacturing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.6.6. Sterile Injectable Contract Manufacturing Market - UAE
    • 9.6.6.1. UAE: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.6.7. Sterile Injectable Contract Manufacturing Market - Israel
    • 9.6.7.1. Israel: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.6.8. Sterile Injectable Contract Manufacturing Market - South Africa
    • 9.6.8.1. South Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.6.9. Sterile Injectable Contract Manufacturing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
• 9.7. Sterile Injectable Contract Manufacturing Market - Latin America
  • 9.7.1. Latin America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.7.5. Sterile Injectable Contract Manufacturing Market - Mexico
    • 9.7.5.1. Mexico: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.7.6. Sterile Injectable Contract Manufacturing Market - Brazil
    • 9.7.6.1. Brazil: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.7.7. Sterile Injectable Contract Manufacturing Market - Argentina
    • 9.7.7.1. Argentina: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)
  • 9.7.8. Sterile Injectable Contract Manufacturing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Molecule Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Therapeutic Application, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Sterile Injectable Contract Manufacturing Market, by End-use, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Baxter
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Catalent, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Vetter Pharma-Fertigung GmbH & Co. KG
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. NextPharma Technologies
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Cipla
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. FAMAR Health Care Services
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Unither Pharmaceuticals
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Recipharm AB
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Fresenius Kabi AG
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Simtra BioPharma Solutions
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Aenova Group
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development